Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2021-11-08 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁恒信律师事务所关于辽宁成大股份有限公司2021年第三次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the convening and procedures of the 2021 third extraordinary general meeting (临时股东大会) of Liaoning Chengda Co., Ltd. It details the review of the company's compliance with relevant laws and regulations, the convening process, attendance, voting procedures, and results. The document does not contain financial statements or results but focuses on the legal validation of the shareholder meeting and its resolutions. It is not a report of financial performance, audit, or management discussion, nor is it a simple announcement or certification. This type of document is best classified under Regulatory Filings (RNS) as it is a legal compliance filing related to corporate governance and shareholder meeting legality, which does not fit other more specific categories.
2021-11-08 Chinese
辽宁成大股份有限公司2021年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2021 年第三季度报告' which translates to '2021 Third Quarter Report'. It contains detailed financial data including income statements, balance sheets, cash flow statements, and notes on financial performance for the third quarter of 2021. The document includes unaudited financial statements and comprehensive financial metrics for the quarter and year-to-date periods. The length of the document is substantial (15,000 characters), and it contains actual financial data and analysis rather than just an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year, containing substantive financial data and analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). 9M 2021
2021-10-29 Chinese
辽宁成大股份有限公司关于股东权益变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a change in shareholder equity, specifically an increase in shareholding by a particular shareholder group. It details the shareholding before and after the transaction, the nature of the transaction (increase in shares), and confirms that the controlling shareholder or actual controller has not changed. The document is titled as a "提示性公告" (prompting or indicative announcement) about shareholder equity changes. It does not contain financial statements, management discussion, or detailed financial results. It is not an annual or interim report, nor a call transcript or audit report. It is a notification of a change in major shareholding levels, which fits the definition of "Major Shareholding Notification (MRQ)". The document length is short (1837 characters), and it is a direct announcement, not a report publication announcement or regulatory filing. Therefore, the correct classification is MRQ with high confidence.
2021-10-28 Chinese
辽宁成大股份有限公司简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of 吉林敖东药业集团股份有限公司 and its concerted actor 吉林敖东延边药业股份有限公司 in 辽宁成大股份有限公司. The document includes specifics about the number of shares held before and after the transaction, the percentage of ownership, the method of acquisition (through the Shanghai Stock Exchange), and the purpose of the equity change. It also references relevant Chinese securities laws and regulations governing disclosure of equity changes. The document is not an annual or interim financial report, nor is it a management or earnings release. It is a formal notification of a change in major shareholding stakes, consistent with the definition of a Major Shareholding Notification (MRQ). The document length (7796 characters) and detailed content confirm it is the report itself, not just an announcement of a report publication or a certification. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2021-10-28 Chinese
辽宁成大股份有限公司关于公司所属子公司辽宁成大生物股份有限公司首次公开发行股票并在科创板上市的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the initial public offering (IPO) and listing of a subsidiary company, 辽宁成大生物股份有限公司, on the Shanghai Stock Exchange's Science and Technology Innovation Board (科创板). It details the approval by regulatory bodies, the issuance and subscription process, share allocation, and the listing date. The document also discusses the impact on the parent company and includes risk warnings. The text is relatively short (1796 characters) and primarily serves as a formal announcement of the IPO and listing event rather than a detailed financial report or prospectus. It references other documents such as the prospectus and listing announcement available on the exchange website but does not contain detailed financial statements or comprehensive analysis itself. Therefore, this document fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as IPOs.
2021-10-26 Chinese
辽宁成大股份有限公司关于2018年度第二期非公开定向债务工具到期兑付公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (490 characters) regarding the maturity and repayment of a specific non-public directed debt instrument issued by the company. It states the debt instrument issuance details, maturity date, and confirmation of repayment. There is no detailed financial data or comprehensive report content. The document is an update on a financing activity, specifically about debt instrument maturity and repayment, which fits the Capital/Financing Update category. It is not a full financial report or audit, nor a regulatory filing or announcement of a report publication. Therefore, the best classification is Capital/Financing Update (CAP).
2021-10-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.